Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beverly Moy

Showing results (11-20 of 168) with videos related to

Pageof 17
Sort By:
The Oncologist|November 18, 2006
Lapatinib: current status and future directions in breast cancerBeverly Moy, Paul E Goss
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2006
Estrogen receptor pathway: resistance to endocrine therapy and new therapeutic approachesBeverly Moy, Paul E Goss
The Oncologist|August 2, 2011
Patient navigator programs, cancer disparities, and the patient protection and affordable care actBeverly Moy, Bruce A Chabner
The Oncologist|August 4, 2007
Lapatinib-associated toxicity and practical management recommendationsBeverly Moy, Paul E Goss
JCO Oncology Practice|November 12, 2024
Deficits of Molecular Prognosis/Diagnosis Studies in Underserved PopulationsArielle J Medford, Beverly Moy
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
Value of cancer care: ethical considerations for the practicing oncologistReshma Jagsi, Daniel P Sulmasy, Beverly Moy
Cancer|August 11, 2021
Disparities in phase 1 cancer clinical trial enrollmentSubha Perni, Beverly Moy, Ryan D Nipp
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2023
Chemotherapy and Targeted Therapy for Endocrine-Pretreated or Hormone Receptor-Negative Metastatic Breast Cancer: ASCO Guideline Rapid Recommendation UpdateBeverly Moy, R Bryan Rumble, Lisa A Carey, et al.
Nature Reviews. Drug Discovery|July 20, 2007
LapatinibBeverly Moy, Peter Kirkpatrick, Santwana Kar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2022
Chemotherapy and Targeted Therapy for Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That Is Either Endocrine-Pretreated or Hormone Receptor-Negative: ASCO Guideline Rapid Recommendation UpdateBeverly Moy, R Bryan Rumble, Lisa A Carey, et al.
Pageof 17

Showing results (11-20 of 168) with videos related to

Sort By:
Pageof 17
The Oncologist|November 18, 2006
Lapatinib: current status and future directions in breast cancerBeverly Moy, Paul E Goss
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2006
Estrogen receptor pathway: resistance to endocrine therapy and new therapeutic approachesBeverly Moy, Paul E Goss
The Oncologist|August 2, 2011
Patient navigator programs, cancer disparities, and the patient protection and affordable care actBeverly Moy, Bruce A Chabner
The Oncologist|August 4, 2007
Lapatinib-associated toxicity and practical management recommendationsBeverly Moy, Paul E Goss
JCO Oncology Practice|November 12, 2024
Deficits of Molecular Prognosis/Diagnosis Studies in Underserved PopulationsArielle J Medford, Beverly Moy
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
Value of cancer care: ethical considerations for the practicing oncologistReshma Jagsi, Daniel P Sulmasy, Beverly Moy
Cancer|August 11, 2021
Disparities in phase 1 cancer clinical trial enrollmentSubha Perni, Beverly Moy, Ryan D Nipp
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2023
Chemotherapy and Targeted Therapy for Endocrine-Pretreated or Hormone Receptor-Negative Metastatic Breast Cancer: ASCO Guideline Rapid Recommendation UpdateBeverly Moy, R Bryan Rumble, Lisa A Carey, et al.
Nature Reviews. Drug Discovery|July 20, 2007
LapatinibBeverly Moy, Peter Kirkpatrick, Santwana Kar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2022
Chemotherapy and Targeted Therapy for Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That Is Either Endocrine-Pretreated or Hormone Receptor-Negative: ASCO Guideline Rapid Recommendation UpdateBeverly Moy, R Bryan Rumble, Lisa A Carey, et al.
Pageof 17